Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum
Background: Cysteamine has recently been shown to have in vitro properties potentially therapeutically beneficial in cystic fibrosis (CF). In this study we investigated the antimicrobial and mucolytic activity of cysteamine against the complex biologic matrix of CF sputum. Methods: Sputum samples we...
Main Authors: | Graham Devereux, Douglas Fraser-Pitt, Jennifer Robertson, Edward Devlin, Derry Mercer, Deborah O'Neil |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-10-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396415301109 |
Similar Items
-
Cysteamine/Cystamine Exert Anti-<i>Mycobacterium abscessus</i> Activity Alone or in Combination with Amikacin
by: Ivana Palucci, et al.
Published: (2023-01-01) -
Mycobacterium abscessus complex: Natural history and treatment outcomes at a tertiary adult cystic fibrosis center
by: Emma Tippett, et al.
Published: (2018-01-01) -
Pseudomonas aeruginosa transcriptome analysis of metal restriction in ex vivo cystic fibrosis sputum
by: Samuel L. Neff, et al.
Published: (2024-04-01) -
Decontamination Strategies Used for AFB Culture Significantly Reduce the Viability of <i>Mycobacterium abscessus</i> Complex in Sputum Samples from Patients with Cystic Fibrosis
by: Dominic Stephenson, et al.
Published: (2021-07-01) -
Molecular typing of Mycobacterium Abscessus isolated from cystic fibrosis patients
by: Alberto Trovato, et al.
Published: (2017-01-01)